Latest Earnings Results: Q1 '27
Estimated EPS
---
Reported EPS
-$0.08
Surprise
---
Estimated Rev
---
Reported Rev
$0.2M
Surprise
---
• Reported GAAP EPS of -$0.06 up 25.00% YoY • Reported revenue of $0.91M up 115.40% YoY • RenovoRx raised and tightened its full-year 2026 revenue guidance to a range of $3.75 million to $4.25 million, up from the prior range of $3.0 million to $4.0 million.
Generated by Stocktwits using AI and company-reported earnings data for Q1 '27. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '27 | -- | -$0.08 | -- | N/A |
Q1 '27 | -- | -$0.08 | -- | N/A |
Q3 '26 | -$0.06 | -- | -- | N/A |
Q2 '26 | -$0.07 | -$0.06 | 17.24% | BEAT |
Q1 '26 | -$0.08 | -$0.09 | -12.50% | MISSED |